Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Hatteras Venture Partners is a venture capital firm founded in the Research Triangle, North Carolina. The firm specializes in early-stage investments in the healthcare sector, focusing on biotech, MedTech, and HealthTech. They manage a portfolio that includes notable companies like G1 Therapeutics, Inc.
Hatteras Venture Partners invests in pre-seed to Series A healthcare companies innovating in therapeutic and diagnostic technologies. Their strategy emphasizes identifying high-quality science and teams that can significantly impact patient care. The firm is particularly interested in companies addressing challenges in emergency care, chronic lung diseases, and gene therapy.
Notable portfolio companies include 410 Medical, which develops resuscitation technologies; Aer Therapeutics, focused on inhaled therapies for chronic lung diseases; Atsena Therapeutics, a gene therapy company targeting inherited retinal diseases; and Cardiosense, which combines wearable sensors with AI for cardiac disease detection. G1 Therapeutics, Inc. went public in May 2017.
Submit your pitch through their website's contact form or email them directly with your deck for consideration.
Yes, Hatteras Venture Partners often leads investment rounds, particularly in their focus areas within healthcare.
The firm is open to follow-on investments, especially for companies that demonstrate significant progress and alignment with their investment thesis.
Specific fund size details are not disclosed, but they actively manage a portfolio of early-stage healthcare companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.